Search company, investor...


Founded Year



Series A | Alive

Total Raised


Last Raised

$20.3M | 2 mos ago

About mitoLab

mitoLab offers biochemicals for non-clinical science research. mitoLab's customers range from multinational companies to individuals specializing in mitochondrial, metabolic, and anti-aging research. The company was founded in 2016 and is based in Cambridge, Massachusetts.

Headquarters Location

700 Main Street

Cambridge, Massachusetts, 02139,

United States

Missing: mitoLab's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: mitoLab's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

mitoLab Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

mitoLab Rank

mitoLab Frequently Asked Questions (FAQ)

  • When was mitoLab founded?

    mitoLab was founded in 2016.

  • Where is mitoLab's headquarters?

    mitoLab's headquarters is located at 700 Main Street, Cambridge.

  • What is mitoLab's latest funding round?

    mitoLab's latest funding round is Series A.

  • How much did mitoLab raise?

    mitoLab raised a total of $23.02M.

  • Who are the investors of mitoLab?

    Investors of mitoLab include Versant Ventures, Neoteny and E14 Fund.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.